Impact of Screening Patients With HIV for Kidney Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00392132|
Recruitment Status : Withdrawn (Sufficient study funding was not obtained.)
First Posted : October 25, 2006
Last Update Posted : May 30, 2018
|Condition or disease|
|HIV Infections Renal Insufficiency, Chronic Proteinuria|
The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. However nobody knows for sure whether this will help doctors take better care of patient with HIV.
This study looks at the effect of this new screening program. We want to see how frequently abnormalities are seen on screening, how frequently certain kidney diseases are diagnosed, how often patients are referred to a nephrologist and how often a patient's management is changed by the screening. We will also estimate the cost-benefit ratio of the screening. We will review patient charts to determine what has happened in each case where screening was conducted.
This study will not involve any additional testing.
The benefit of this study will be improving our understanding of kidney disease in HIV. It will help us determine the value of screening for kidney disease and the frequency of certain kidney diseases in HIV in our clinic population.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Impact of Screening Patients With HIV for Kidney Disease|
|Study Start Date :||October 2005|
|Estimated Primary Completion Date :||October 2006|
|Estimated Study Completion Date :||October 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00392132
|United States, Mississippi|
|University of Mississippi Medical Center|
|Jackson, Mississippi, United States, 39216-4505|
|Principal Investigator:||Darren W Schmidt, MD||University of Mississippi Medical Center|